Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOAP II
NCT00314704Phase 3Completed
- Start
- Dec 2003
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dopamine, norepinephrine in Shock. Started Dec 2003; status: completed.
02
Drugs
dopaminenorepinephrine
03
Conditions
Shock
Beyond the preview
Go deeper on NCT00314704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314704.